Stroke Research
- Prevention Clinical Trials
- Recovery Trials
- Acute Ischemic Stroke Trials
- Acute Brain Hemorrhage Trials
- Subarachnoid Hemorrhage Trials
Arteriovenous Malformation (AVM)
bAVM
Purpose: Human Brain Arteriovenous Malformation (bAVM) Molecular Analysis; EndMT as a Target to Treat Human Brain Arteriovenous Malformations.
Principal Investigator: Ping R Chen, MD
Lead CRC: Eddie Aguilar
Contact Us: To learn more about this trial, please fill out this short online form »
Stroke Prevention Trials
CAPTIVA – Comparison of Anti-Coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
Investigator: Anjail Sharrief, MD, MPH, FAHA
Lead CR: Ariana Aquino Hernandez
The purpose of this study is to directly compare novel antithrombotic medications to standard care antiplatelet medications for preventing stroke and death from vascular causes in patients with narrowed brain arteries
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Librexia
Purpose: A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack.
Principal Investigator: Robert J Brown, MD
Lead CRC: Kaitlin Simmons
NCT#: 05702034
Contact Us: To learn more about this trial, please fill out this short online form »
SATURN: StATins Use in intRacerebral hemorrhage patieNts
Investigator: Chen, Jared
Lead CRC: Kristina Ramirez
Purpose: determine the effects of continuation vs. discontinuation of statins on the risk of ICH recurrence
Key Inclusion Criteria: Patients presenting with a spontaneous lobar lCH while taking a statin drug
Enrollment Status: Actively enrolling
NCT#: 03936361
Contact Us: To learn more about this trial, please fill out this short online form »
START – Optimal Delay Time to Initiate Anticoagulation after Ischemic Stroke in Atrial Fibrillation
Investigator: Abdelhamid, Noureldin
Lead CR: Cooksey, Gabretta
Contact Us: To learn more about this trial, please fill out this short online form »
Video-Based Intervention to Reduce Treatment and Outcome Disparities in Adults Living with Stroke or Transient Ischemic Attack (VIRTUAL)
Investigator: Anjail Sharrief, MD, MPH, FAHA
Lead CR: Caitlynn Carter
The purpose of this study is to address the medical and social needs of patients, while providing them with the technology to engage in telehealth intervention. It will provide understanding on the impact of intervention on key clinical outcomes relative to standard care.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
SLEEP SMART – Sleep for Stroke Management and Recovery Trial
Investigator: Anjail Sharrief, MD, MPH, FAHA
Lead CR: Ariana Aquino Hernandez
The primary goals of this study are to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality during 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced in ischemic stroke.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
REACH-ICH – Race/Ethnicity, Hypertension, and Prevention of VCID After Intracerebral Hemorrhage
Investigator: Anjail Sharrief, MD, MPH, FAHA
Lead CR: Mariel Flake-Rojas
The goal of this study is to determine whether modifiable SDOH predict risk of poor hypertension control after ICH thorugh BP monitoring.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
STOP STROKE – Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction
Investigator: Sharrief, Anjail
Lead CR: Cooksey, Gabretta
Ischemic and hemorrhagic stroke.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
WVACHII obs – Registry for Women’s Vascular and Cardiac Health Interdisciplinary Initiative
Investigator: Gonzales, Nicole R
Lead CR: Tulod, Kathleen B
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Recovery Trials
Digital Biomarkers For Vascular Cognitive Decline in Patients with Minor Stroke (MARSH-MEG Cognition)
Investigator: Anjail Sharrief, MD, MPH, FAHA
Lead CR: Ariana Aquino Hernandez
The goals of this study are to identify common patterns of functional brain network disruption and to determine the compensatory changes in functional brain networks over time that allow for improvement and assess early functional network alterations.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
REDUCE – Spironolactone for Blood Pressure Control After Intracerebral Hemorrhage
Investigator: Anjail Sharrief, MD, MPH, FAHA
Lead CR: Mariel Flake-Rojas
The purpose of this study is to compare the effect of spironolactone-containing antihypertensive regimens versus standard antihypertensive regimens on 3-months change in home systolic BP in stroke survivors.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
MicroRNAs, Mitochondria and the Blood-Brain Barrier – Therapeutic Targets for Stroke
Investigator: Xuefang Ren, MD, PhD
Purpose: The objective of this proposal is to investigate if endothelial specific miR-34a affects stroke outcomes in the aged brain. We hypothesize that endothelial miR-34a regulates BBB permeability, ischemic damage, hemorrhagic transformation, and stroke-induced deficits by inhibiting translation of LETM1 and LETMD1 leading to impaired mitochondrial bioenergetics in CECs.
Contact Us: To learn more about this trial, please fill out this short online form »
PREDICT – ICH obs – Predicting Upper Extremity Motor Recovery in Subcortical Hemorrhagic Stroke Using DTI and TMS
Investigator: Sean Savitz, MD (Zafer/Shayan/Aronowski)
Lead CRC: Dorothea Parker
Diagnostics TMS in ICH
Contact Us: To learn more about this trial, please fill out this short online form »
LAPHI obs – Lesion size and Brain Atrophy changes in Patients with Hemorrhagic and Ischemic Stroke (LAPHI)
Investigator: Muhammad Haque, MD
Lead CRC: George, Sarah
Summary Assessment of MRI after stroke
Contact Us: To learn more about this trial, please fill out this short online form »
TRANSPORT-2 – TRANScranial direct current stimulation for Post-stroke motor Recovery – a phase II study
Investigator: Gerard Francisco, MD
Lead CRC: Parker, Dorothea M
Purpose: Upper extremity recovery after ischemic stroke
Key Inclusion Criteria: 1st ever, unilateral ischemic stroke; at least 10 degrees of wrist extension
tDCS+CIMT for with 6 months of 1st ever, unihemispheric AIS.
Contact Us: To learn more about this trial, please fill out this short online form »
PISCES – A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03 DP) in subjects with Disability Following an Ischemic Stroke
Investigator: Savitz, Sean I
Lead CRC: Dorothea Parker
Purpose: Motor recovery
Key Inclusion Criteria: ischemic stroke, wrist extension and shoulder shrug present
Enrollment Status: Actively enrolling
Summary IV Stem cell therapy for chronic IS
Contact Us: To learn more about this trial, please fill out this short online form »
iACQUIRE – Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation
Investigator: Nivedita Thakur, MD
Lead CRC: Dorothea Parker
Purpose: Recovery of upper extremity weakness in neonatal stroke
Key Inclusion Criteria: 8-36 months with unilateral upper extremity deficit
In-home CIMT in chronic pediatric AIS.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Study Name VAST-rehab (Obs) – Virtually Assisted home rehabilitation after Acute Stroke
Investigator: Sean Savitz, MD
Lead CRC: Dorothea Parker
Summary Home-based telerehab after acute stroke (AIS / ICH)
Enrollment Status: On hold
Contact Us: To learn more about this trial, please fill out this short online form »
COPOR Obs Clinical Outcome and Patient Factors in Patient’s outcomes admitted to inpatient rehabilitation facility
Investigator: Sean Savitz, MD
Lead CRC: Dorothea Parker
Purpose: Evaluating the effect of IPR on stroke recovery
Key Inclusion Criteria: admitted to IPR facility within MH system
Retrospective analysis of inpatient rehab and recovery data
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
NCS-01
Investigator: Anjail Sharrief, MD
Lead CRC: Dorothea Parker
Purpose: Recovery
Key Inclusion Criteria: Ischemic stroke; NIHSS 6-18 w/ or w/o TPA/IAT (maintains score after intervention); pre-stroke mRS <3; LSN < 32 hours from planned infusion
Assesses regional patterns of care for ICH
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
BIONICS
Investigator: Sean Savitz, MD
Lead CRC: Dorothea Parker
Purpose: Machine learning
Key Inclusion Criteria: Cleared to participate in rehab activity
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Acute Ischemic Stroke (AIS)
Millipede AspiRation for Revascularization in Stroke (MARRS) Study
Purpose: The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.
Investigator: Michael Nahhas, MD
Lead CRC: Joseph Samaha
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Intrepid – Impact of Fever Prevention in Brain Injured Patients
Investigator: HuiMahn Alex Choi, MD
Lead CRC: Glenda L Torres
IS, ICH, SAH
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Stroke (AIS) Bio-Repository
Investigator: Aronowski, J
Lead CRC: Satani, Nikunj
Biorepository of specimens including blood, CSF and brain tissue
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
SPLENDID
Purpose: Safety, Performance and Lesion Evaluation of Neurothrombectomy using CEREGLIDE 92 Intermediate Catheter: A Prospective Multi-Center Single-Arm IDE Trial
Principal Investigator: Ping R Chen, MD
Lead CRC: Eddie Aguilar
Enrollment status: Upcoming
NCT#: 06386289
Contact Us: To learn more about this trial, please fill out this short online form »
Acute Brain Hemorrhage Trials
Andexanet-Alpha
Purpose: Early administration and treatment of factor Xa related intracranial hemorrhage on a Mobile Stroke Unit: A prospective pilot feasibility study.
Principal Investigator: Ritvij Bowry, MD
Lead CRC: Glenda Torres.
BEACH
Purpose: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage.
Principal Investigator: Tiffany Chang, MD
Lead CRC: Glenda Torres
NCT#: 05020535
FASTEST (start up pending) – Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Investigator: James Grotta
Lead CR: Bratina, Patti L
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Novartis
Investigator: HuiMahn Alex Choi, MD
Lead CRC: Glenda Torres
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Intrepid – Impact of Fever Prevention in Brain Injured Patients
Investigator: HuiMahn Alex Choi, MD
Lead CRC: Torres, Glenda L
AIS, ICH, SAH
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
CAA-ICH – Developing a Biochemical Test to Differentiate Cerebral Amyloid Angiopathy-Intracerebral Hemorrhage from Hypertensive Hemorrhage (obs)
Investigator: Gonzales, Nicole R
Lead CRC: Kathleen Tulod
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Hemostasis obs
Investigator: Chang, Tiffany R
Lead CRC: Torres, Glenda L
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Subarachnoid Hemorrhage Trials
Intrepid – Impact of Fever Prevention in Brain Injured Patients
Investigator: HuiMahn Alex Choi
Lead CR: Glenda L Torres
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Mani bio-Repository
Investigators: Huimahn Alex Choi/Tiffany Chang
Lead CR: Glenda L Torres
Enrollment Status: Actively Enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Chronic Subdural Hematoma Treatment with Embolization Versus Surgery Study (CHESS)
Investigator:Sunil Sheth, MD
Lead CR: Joseph Samaha
Safety and efficacy of Middle meningeal artery embolization compared to conventional surgery for moderately symptomatic convexity chronic subdural hematoma (CSDH)
Enrollment Status: Enrolling soon
Contact Us: To learn more about this trial, please fill out this short online form »
Millipede AspiRation for Revascularization in Stroke Study (MARRS)
Investigator: Michael Nahhas, MD
Lead CR: Joseph Samaha
The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
STRATEGY FOR IMPROVING STROKE TREATMENT RESPONSE TRIAL (SISTER)
Investigator: Andrew Barreto, MD
Lead CR: Prasen Marella
To identify a dose of TS23 (monoclonal antibody against alpha-2 anti-plasmin) that is safe and more efficacious than placebo for the treatment of patients from 4.5 to 24 hours of ischemic stroke onset (or last known well), who have evidence of core-penumbra mismatch on perfusion imaging and are not a candidate for standard of care reperfusion therapies
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
ReMEDy2 Trial
Investigator: Andrew Barreto, MD
Lead CR: Prasen Marella
Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of DM199( Recombinant human tissue kallikrein-1) for the Treatment of acute ischemic stroke presenting within 24 hrs. of last seen normal or symptom onset.
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery (ASPIRE)
Investigator: Andrew Barreto, MD
Lead CR: Prasen Marella
To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation. To determine if apixaban, compared to aspirin, results in better functional outcomes as measured by the modified Rankin scale
Enrollment Status: Actively enrolling
Contact Us: To learn more about this trial, please fill out this short online form »
Clinical Trials
Please fill out the fields to receive information about an ongoing UTHealth Neurosciences clinical trial.